Ознакомительная версия. Доступно 15 страниц из 73
Cosmos Magazine, April 27, 2015.
Overholser, Winfred. “Has Chlorpromazine Inaugurated a New Era in Mental Hospitals?” J Clin Exp Psychophathol Q Rev Psychiatry Neurol 17, no. 2 (1956): 197–201.
Pacific Northwest Evidence-Based Practice Center. “Statins for Prevention of Car-diovascular Disease in Adults: Systematic Review for the U.S. Preventive Services Task Force.” Evidence Synthesis 139 (2015).
Payte, J. Thomas. “A Brief History of Methadone in the Treatment of Opioid Depen-dence: A Personal Perspective.” J Psychoactive Drugs 23, no. 2 (1991): 103–7.
Pead, Patrick J. “Benjamin Jesty: New Light in the Dawn of Vaccination.” Lancet 362 (2003): 2,104–9.
––. The Homespun Origins of Vaccination: A Brief History. Sussex: Timefile Books, 2017.
Perrine, Daniel M. The Chemistry of Mind-Altering Drugs: History, Pharmacology, and Cultural Context. Washington, D.C.: American Chemical Society, 1996.
Petrovska, Biljana Bauer. “Historical Review of Medicinal Plants’ Usage.” Pharma-cogn Rev 6, no. 11 (2012): 1–5.
Planned Parenthood Federation of America. The Birth Control Pill: A History. 2015. https://www.plannedparenthood.org/f iles/1514/3518/7100/Pill _History_FactSheet.pdf Pringle, Peter. Experiment Eleven. New York: Walker & Company, 2012.
Potts, Malcolm. “Two Pills, Two Paths: A Tale of Gender Bias.” Endeavour 27, no. 3 (2003): 127–30.
Ratti, Emiliangel, and David Trist. “Continuing Evolution of the Drug Discovery Pro-cess in the Pharmaceutical Industry.” Pure Appl Chem 73, no. 1 (2001): 67–75.
Raviña, Enrique. The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs. Weinheim, Germany: Wiley-VCH, 2011.
Razzell, Peter. The Conquest of Smallpox. Sussex, UK: Caliban Books, 1977.
Ribatti, Domenico. “From the Discovery of Monoclonal Antibodies to Their Therapeutic Application: An Historical Reappraisal.” Immunol Lett 161 (2014): 96–99.
Rice, Kenner C. “Analgesic Research at the National Institutes of Health: State of the Art 1930s to Present.” In Opioids and Pain Relief: A Historical Perspective, edited by Marcia L. Meldrum, 57–83. Seattle: IASP Press, 2003.
Ridker, Paul M., et al. “Cardiovascular Benefits and Diabetes Risks of Statin Ther-apy in Primary Prevention: An Analysis from the JUPITER Trial.” Lancet 380, no. 9841 (2012): 565–71.
Robins, Nick. “The Corporation That Changed the World: How the East India Com-pany Shaped the Modern Multinational.” Asian Aff 43, no. 1 (2012): 12–26.
Robinson, Jennifer G., and Ray Kausik. “Moving Toward the Next Paradigm for Cardiovascular Prevention.” Circulation 133 (2016): 1,533–6.
Rosner, Lisa. Vaccination and Its Critics. Santa Barbara: Greenwood, 2017. Santoro, Domenica, et al. “Development of the concept of pain in history.” J Nephrol 24(S17) (2011): S133–S136.
Schwartz, J. Stanford. “Primary Prevention of Coronary Heart Disease with Statins: It’s Not About the Money.” Circulation 124 (2011): 130–2.
Shaw, Daniel L. “Is Open Science the Future of Drug Development?” Yale J Bio Med 90 (2017): 147–51.
Shorter, Edward. A History of Psychiatry: From the Era of the Asylum to the Age of Prozac. New York: John Wiley & Sons, 1997.
Shorter, Edwin, ed. An Oral History of Neuropsychopharmacology, The First Fifty Years, Peer Interviews, vol. 1. Brentwood, TN: ACNP, 2011.
Siegel, Ronald K. Intoxication: The Universal Drive for Mind-Altering Drugs. Roch-ester: Park St. Press., 2005
Silverstein, Arthur M., and Genevieve Miller. “The Royal Experiment on Immunity: 1721–22.” Cellular Immunol 61 (1981): 437–47.
Sneader, Walter. “The 50th Anniversary of Chlorpromazine.” Drug News Perspect 15, no. 7 (2002): 466–71
––. Drug Discovery: A History. Sussex, UK: John Wiley & Sons, 2005.
Snelders, Stephen, et al. “On Cannabis, Chloral Hydrate, and the Career Cycles of Psychotropic Drugs in Medicine.” Bull Hist Med 80 (2006): 95–114.
Stanley, Theodore H. “The Fentanyl Story.” J Pain 15, no. 12 (2014): 1,215–26.
Stewart, Alexandra J., and Phillip M. Devlin. “The History of the Smallpox Vaccine.” Journal of Infect 52 (2005): 329–34.
Stossel, Thomas P. “The Discovery of Statins.” Cell 134 (2008): 903–5.
Sugiyama, Takehiro, et al. “Different Time Trends of Caloric and Fat Intake Between Statin Users and Nonusers Among US Adults: Gluttony in the Time of Statins?” JAMA Intern Med 174, no. 7 (2014): 1,038–45.
Sun, Gordon H. “Statins: The Good, the Bad, and the Unknown.” Medscape, Octo-ber 10, 2014.
Swazey, Judith P. Chlorpromazine in Psychiatry: A Study of Therapeutic Innovation. Cambridge, MA: MIT Press, 1974.
Taylor, Fiona, et al. “Statin Therapy for Primary Prevention of Cardiovascular Dis-ease.” JAMA 310, no. 22 (2013): 2,451–2.
Temin, Peter. Taking Your Medicine: Drug Regulation in the United States. Cam-bridge: Harvard University Press, 1980.
Tone, Andrea. The Age of Anxiety. New York: Basic Books, 2009.
Tone, Andrea, and Elizabeth Siegel Watkins. Medicating Modern America: Prescription Drugs in History. New York: New York University Press, 2007.
Wade, Nicholas. “Hybridomas: The Making of a Revolution.” Science 215, no. 26 (1982): 1,073–5.
Wallace, Edwin R., and John Gach, eds. History of Psychiatry and Medical Psychology. New York: Springer, 2008.
Wanamaker, Brett L., et al. “Cholesterol, Statins, and Dementia: What the Cardiologist Should Know.” Clin Cardiol 38, no. 4 (2015): 243–50.
Whitaker, Robert. Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill. New York: Basic Books, 2002.
Yamada, Taketo. “Therapeutic Monoclonal Antibodies.” Keio J Med 60, no. 2 (2011): 37–46.
Zaimeche, Salah, et al. “Lady Montagu and the Introduction of Smallpox Inoculation to England.” www.muslimheritage.com/article/lady-montagu-and – introduction-smallpox-inoculation-england.
* * *
Примечания
1
В настоящее время безрецептурный оборот кодеинсодержащих средств запрещен в РФ из-за высокой опасности возникновения зависимости. – Прим. ред.
2
То есть секрет, который и так всем известен, мнимая тайная. – Прим. ред.
3
Оригинал книги вышел в 2019 году. – Прим. ред.
Ознакомительная версия. Доступно 15 страниц из 73
